SVRA - Savara Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Global Select Current Price & Safety Score Price: 4.52 USD StockBonds Safety Grade: D Altman Z-Score (Bankruptcy Risk): 4.35 StockBond Score: -2.07 Company Description Savara Inc is a biopharmaceutical firm in the clinical development phase specializing in therapies for uncommon respiratory conditions Their primary investigational drug molgramostim is an inhaled form of granulocytemacrophage colonystimulating factor GMCSF This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis The companys main operations are situated in Austin Texas